Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02923830 · ClinicalTrials.gov registry record · Phase 4
Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes
A Phase 4 study, sponsored by TriHealth.
- Terminated
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT02923830 is a Phase 4 study that was terminated before completion, run by TriHealth. The registered enrollment target is 28 participants.
The verdict
NCT02923830, a Phase 4 study, was terminated before completion, sponsored by TriHealth.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in BioFlo implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients whose ports are flushed with a combination of saline and heparinized saline.
Interventions
- OTHER Heparinized saline catheter flush
- DRUG Saline-only catheter flush
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-04 |
| Est. Completion | 2019-03-26 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02923830
The ClinicalTrials.gov registry entry for NCT02923830 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Heparinized saline catheter flush is the first listed.
NCT02923830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02923830 about?
NCT02923830 is a clinical study titled "Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes". The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in BioFlo implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients w...
What is the current status of trial NCT02923830?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2016-04. Estimated completion is 2019-03-26.
What interventions are being tested in trial NCT02923830?
The interventions under investigation include: Heparinized saline catheter flush (OTHER), Saline-only catheter flush (DRUG).
Who is sponsoring clinical trial NCT02923830?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.